{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:56:46Z","timestamp":1787677006214,"version":"build-2784847793"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017209","name":"Foundation Institute of Health Research of Santiago de Compostela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.trsl.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T16:45:48Z","timestamp":1708533948000},"page":"47-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers"],"prefix":"10.1016","volume":"269","author":[{"given":"Laura","family":"L\u00f3pez-Valverde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E.","family":"V\u00e1zquez-Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00f3bal","family":"Col\u00f3n-Mejeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana B.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Barbosa-Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. V\u00edctor","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"S\u00e1nchez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"L\u00f3pez-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"L\u00f3pez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Villacorta-Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Goicoechea-Diezhandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Guerrero-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saida","family":"Ortolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Leao-Teles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Hermida-Ameijeiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-9905","authenticated-orcid":false,"given":"Mar\u00eda L.","family":"Couce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2024.02.006_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","article-title":"Fabry's disease","volume":"344","author":"El-Abassi","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.trsl.2024.02.006_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biom11020271","article-title":"Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions","volume":"11","author":"Kok","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.trsl.2024.02.006_bib0003","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2024.02.006_bib0004","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Anderson-Fabry disease: a multiorgan disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.trsl.2024.02.006_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.trsl.2024.02.006_bib0006","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) controversies conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2024.02.006_bib0007","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00431-017-2950-8","article-title":"Newborn screening for Fabry disease in the north-west of Spain","volume":"176","author":"Colon","year":"2017","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.trsl.2024.02.006_bib0008","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.3390\/ijms21218080","article-title":"Biomarkers in Anderson-Fabry disease","volume":"21","author":"Simonetta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2024.02.006_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/TACG.S146022","article-title":"Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype- phenotype correlations","volume":"12","author":"Oliveira","year":"2019","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0011","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2020.10.006","article-title":"Proteomics for the study of new biomarkers in Fabry disease: state of the art","volume":"132","author":"Rossi","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0012","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10545-010-9261-9","article-title":"Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group","volume":"34","author":"Gal","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.trsl.2024.02.006_bib0013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2016.07.001","article-title":"Fabry disease: a disorder of childhood onset","volume":"64","author":"Schiffmann","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0014","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCEP.114.002569","article-title":"Pathology and function of conduction tissue in Fabry disease cardiomyopathy","volume":"8","author":"Frustaci","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0015","first-page":"790","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0016","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/metabo12080703","article-title":"Metabolic fingerprinting of Fabry disease: diagnostic and prognostic aspects","volume":"12","author":"Rocchetti","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.trsl.2024.02.006_bib0017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/cge.13546","article-title":"Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients","volume":"96","author":"Germain","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0018","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1039\/C4MB00707G","article-title":"Early markers of Fabry disease revealed by proteomics","volume":"11","author":"Matafora","year":"2015","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.trsl.2024.02.006_bib0019","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1021\/pr301200e","article-title":"The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients","volume":"12","author":"Manwaring","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0020","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3109\/0886022X.2010.516859","article-title":"Study of urinary proteomes in Anderson-Fabry disease","volume":"32","author":"Vojtov\u00e1","year":"2010","journal-title":"Ren Fail"},{"key":"10.1016\/j.trsl.2024.02.006_bib0021","doi-asserted-by":"crossref","first-page":"e20534","DOI":"10.1371\/journal.pone.0020534","article-title":"A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy","volume":"6","author":"Kistler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2024.02.006_bib0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmedgenet-2019-106030","article-title":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease","volume":"57","author":"Doykov","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009098","article-title":"Elevated inflammatory plasma biomarkers in patients with Fabry disease: a critical link to heart failure with preserved ejection fraction","volume":"7","author":"Yogasundaram","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trsl.2024.02.006_bib0024","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmedgenet-2017-104704","article-title":"Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy","volume":"54","author":"Heo","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0025","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.0611315104","article-title":"Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities","volume":"104","author":"Moore","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2024.02.006_bib0026","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ejhf.230","article-title":"Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease","volume":"17","author":"Hollander","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.trsl.2024.02.006_bib0027","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/jcm9051325","article-title":"A proteomics-based analysis reveals predictive biological patterns in Fabry disease","volume":"9","author":"Tebani","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trsl.2023.02.006","article-title":"Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease","volume":"258","author":"Tebani","year":"2023","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0029","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/jhh.2011.104","article-title":"Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies","volume":"26","author":"Cuspidi","year":"2012","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.trsl.2024.02.006_bib0031","first-page":"e239","article-title":"Correction to: an updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association\/American stroke association","volume":"50","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.trsl.2024.02.006_bib0032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.colsurfb.2019.01.056","article-title":"Proteomic analysis of the bio-corona formed on the surface of (Au, Ag, Pt)-nanoparticles in human serum","volume":"177","author":"del Pilar Chantada-V\u00e1zquez","year":"2019","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.trsl.2024.02.006_bib0033","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.3390\/ijms22116165","article-title":"Plasma proteomic analysis in morquio a disease","volume":"22","author":"\u00c1lvarez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2024.02.006_bib0034","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"10.1016\/j.trsl.2024.02.006_bib0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jprot.2016.02.010","article-title":"Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction","volume":"138","author":"Ortea","year":"2016","journal-title":"J Proteomics"},{"key":"10.1016\/j.trsl.2024.02.006_bib0036","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jprot.2018.01.003","article-title":"Identification of candidate serum biomarkers of childhood-onset growth hormone deficiency using SWATH-MS and feature selection","volume":"175","author":"Ortea","year":"2018","journal-title":"J Proteomics"},{"key":"10.1016\/j.trsl.2024.02.006_bib0037","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0038","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.789142","article-title":"Endothelial dysfunction in fabry disease is related to glycocalyx degradation","volume":"12","author":"Pollmann","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2350-7-11","article-title":"Gene expression profiles in Finnish twins with multiple sclerosis","volume":"7","author":"S\u00e4rkij\u00e4rvi","year":"2006","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0041","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2119\/molmed.2015.00187","article-title":"Upregulation and mitochondrial sequestration of hemoglobin occur in circulating leukocytes during critical illness, conferring a cytoprotective phenotype","volume":"21","author":"Brunyanszki","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0042","first-page":"253","article-title":"Expression profiling of PBMC-based diagnostic gene markers isolated from vasculitis patients","volume":"15","author":"Kobayashi","year":"2008","journal-title":"DNA Res Int J Rapid Publ Reports Genes genomes"},{"key":"10.1016\/j.trsl.2024.02.006_bib0043","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41540-019-0105-4","article-title":"Genetic signature related to heme-hemoglobin metabolism pathway in sepsis secondary to pneumonia","volume":"5","author":"Leite","year":"2019","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.trsl.2024.02.006_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.709173","article-title":"The role of hemoglobin subunit delta in the immunopathy of multiple sclerosis: mitochondria matters","volume":"12","author":"Derakhshani","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0045","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2024.02.006_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125934","article-title":"Evaluation of iTRAQ and SWATH-MS for the quantification of proteins associated with insulin resistance in human duodenal biopsy samples","volume":"10","author":"Bourassa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2024.02.006_bib0047","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12014-018-9201-5","article-title":"Comparison of iTRAQ and SWATH in a clinical study with multiple time points","volume":"15","author":"Jylh\u00e4","year":"2018","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.trsl.2024.02.006_bib0048","first-page":"d1356","article-title":"S100 proteins: structure, functions and pathology","volume":"7","author":"Heizmann","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.trsl.2024.02.006_bib0049","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2004-07-2520","article-title":"Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells","volume":"105","author":"Viemann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2024.02.006_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001025","article-title":"From bench to bedside: Calprotectin (S100A8\/S100A9) as a biomarker in rheumatoid arthritis","volume":"13","author":"Inciarte-Mundo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0051","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/jc.2007-1910","article-title":"Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients","volume":"93","author":"Joseph","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105462","article-title":"Ficolin-2 serum levels predict the occurrence of acute coronary syndrome in patients with severe carotid artery stenosis","volume":"166","author":"Carbone","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0053","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.thromres.2004.07.017","article-title":"Beta 2 glycoprotein I\u2013function in health and disease","volume":"114","author":"Miyakis","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0054","doi-asserted-by":"crossref","first-page":"13230","DOI":"10.1038\/s41598-019-49429-x","article-title":"A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients","volume":"9","author":"Rodr\u00edguez-Carrio","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2024.02.006_bib0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1369\/0022155420940067","article-title":"The inter-\u03b1-trypsin inhibitor family: versatile molecules in biology and pathology","volume":"68","author":"Lord","year":"2020","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"key":"10.1016\/j.trsl.2024.02.006_bib0056","first-page":"401","article-title":"Expression of genes and their responses to enzyme replacement therapy in a Fabry disease mouse model","volume":"24","author":"Park","year":"2009","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0057","first-page":"148","article-title":"The lectin pathway of complement and rheumatic heart disease","volume":"2","author":"Beltrame","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.trsl.2024.02.006_bib0058","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99171","article-title":"Neuropathic pain in a Fabry disease rat model","volume":"3","author":"Miller","year":"2018","journal-title":"JCI insight"},{"key":"10.1016\/j.trsl.2024.02.006_bib0059","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwi041","article-title":"Lysosomal metabolism of glycoproteins","volume":"15","author":"Winchester","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.trsl.2024.02.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/205948","article-title":"Urine bikunin as a marker of renal impairment in Fabry's disease","volume":"2013","author":"Lepedda","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trsl.2024.02.006_bib0061","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.trsl.2024.02.006_bib0062","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2024.02.006_bib0063","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ebiom.2017.02.009","article-title":"Antithrombin III protects against contrast-induced nephropathy","volume":"17","author":"Lu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trsl.2024.02.006_bib0064","first-page":"671","article-title":"Multiple roles of histidine-rich glycoprotein in vascular homeostasis and angiogenesis","volume":"75","author":"Gao","year":"2021","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.trsl.2024.02.006_bib0065","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1111\/bph.14711","article-title":"Histidine-rich glycoprotein ameliorates endothelial barrier dysfunction through regulation of NF-\u03baB and MAPK signal pathway","volume":"176","author":"Gao","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0066","first-page":"63","article-title":"Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: impacts on thrombosis and thrombolysis","volume":"11","author":"Ekmekci","year":"2005","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb"},{"key":"10.1016\/j.trsl.2024.02.006_bib0067","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1160\/TH08-02-0078","article-title":"Elevated plasma fibronectin levels associated with venous thromboembolism","volume":"100","author":"Pecheniuk","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2024.02.006_bib0068","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tcm.2004.04.001","article-title":"The functions of plasminogen in cardiovascular disease","volume":"14","author":"Plow","year":"2004","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0069","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191865","article-title":"A critical role for plasminogen in inflammation","volume":"217","author":"Baker","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0070","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1039\/c3mb25402j","article-title":"Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings","volume":"9","author":"Cigna","year":"2013","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.trsl.2024.02.006_bib0071","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1991.102","article-title":"Diagnostic significance of hypocomplementemia","volume":"39","author":"Hebert","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2024.02.006_bib0072","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymgme.2017.07.012","article-title":"The role of epigenetics in lysosomal storage disorders: uncharted territory","volume":"122","author":"Hassan","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0073","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1096\/fba.2021-00108","article-title":"Systemic deficiency of vitronectin is associated with aortic inflammation and plaque progression in ApoE-Knockout mice","volume":"4","author":"Chakravarty","year":"2022","journal-title":"FASEB bioAdvances"},{"key":"10.1016\/j.trsl.2024.02.006_bib0074","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.1073\/pnas.1201433109","article-title":"Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2024.02.006_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOL.0000000000000371","article-title":"Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney function","volume":"28","author":"Kronenberg","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0076","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2796.2012.02585.x","article-title":"Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus\u2013a post hoc analysis of the 4D Study","volume":"272","author":"Kollerits","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0077","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0078","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/joim.12380","article-title":"Association between apolipoprotein A-IV concentrations and chronic kidney disease in two large population-based cohorts: results from the KORA studies","volume":"278","author":"Stangl","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.trsl.2024.02.006_bib0079","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1681\/ASN.2005070733","article-title":"Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"17","author":"Boes","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"T\u00f8ndel","year":"2008","journal-title":"Am J kidney Dis Off J Natl Kidney Found"},{"key":"10.1016\/j.trsl.2024.02.006_bib0081","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ymgme.2014.08.007","article-title":"Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis","volume":"114","author":"van der Tol","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0082","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.ymgme.2018.12.269","article-title":"Proteomic profiling of engineered human immortalized podocyte cell model of Fabry disease","volume":"126","author":"Neto","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2024.02.006_bib0083","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1021\/acs.jproteome.5b00060","article-title":"A cluster of proteins implicated in kidney disease is increased in high-density lipoprotein isolated from hemodialysis subjects","volume":"14","author":"Shao","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0084","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2215\/CJN.11321017","article-title":"Alteration of HDL protein composition with hemodialysis initiation","volume":"13","author":"Wang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0085","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0086","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12944-016-0326-0","article-title":"APOC3 induces endothelial dysfunction through TNF-\u03b1 and JAM-1","volume":"15","author":"Tao","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.trsl.2024.02.006_bib0087","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/ATVBAHA.110.221846","article-title":"Apolipoprotein CIII: 42 years old and even more interesting","volume":"31","author":"Ginsberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0088","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20070308","article-title":"Apolipoprotein C-III: understanding an emerging cardiovascular risk factor","volume":"114","author":"Ooi","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trsl.2024.02.006_bib0089","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCRESAHA.110.234260","article-title":"Fetuin-A regulation of calcified matrix metabolism","volume":"108","author":"Jahnen-Dechent","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.945287","article-title":"The structure, biosynthesis, and biological roles of fetuin-A: a review","volume":"10","author":"Chekol Abebe","year":"2022","journal-title":"Front cell Dev Biol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0091","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41556-018-0215-z","article-title":"Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via \u03b2-catenin","volume":"20","author":"Jung","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0092","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/cells10071768","article-title":"Transthyretin: from structural stability to osteoarticular and cardiovascular diseases","volume":"10","author":"Wieczorek","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2024.02.006_bib0093","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163804","article-title":"Up-Regulation of antioxidant proteins in the plasma proteome during saturation diving: unique coincidence under hypobaric hypoxia","volume":"11","author":"Domoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2024.02.006_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101942","article-title":"Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation","volume":"41","author":"Sun","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0095","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.3390\/ijms22126408","article-title":"Critical role of hemopexin mediated cytoprotection in the pathophysiology of sickle cell disease","volume":"22","author":"Ashouri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2024.02.006_bib0096","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCRESAHA.116.310266","article-title":"ATF6 decreases myocardial ischemia\/reperfusion damage and links ER stress and oxidative stress signaling pathways in the heart","volume":"120","author":"Jin","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2024.02.006_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767981","article-title":"SARS-CoV-2 antibodies mediate complement and cellular driven inflammation","volume":"12","author":"Jarlhelt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0098","doi-asserted-by":"crossref","first-page":"22511","DOI":"10.1038\/s41598-021-02011-w","article-title":"Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease","volume":"11","author":"Irmscher","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2024.02.006_bib0099","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molimm.2022.03.117","article-title":"Complement Factor H related protein 1 and immune inflammatory disorders","volume":"145","author":"Li","year":"2022","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nmeth.3234","article-title":"DIA mass spectrometry","volume":"12","author":"Doerr","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.trsl.2024.02.006_bib0101","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.15252\/msb.20178126","article-title":"Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial","volume":"14","author":"Ludwig","year":"2018","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.trsl.2024.02.006_bib0102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00249-5","article-title":"Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry","volume":"8","author":"Collins","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2024.02.006_bib0103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pmic.201600278","article-title":"SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications","volume":"17","author":"Anjo","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.trsl.2024.02.006_bib0104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jprot.2018.02.026","article-title":"SWATH mass spectrometry as a tool for quantitative profiling of the matrisome","volume":"189","author":"Krasny","year":"2018","journal-title":"J Proteomics"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524424000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524424000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T04:01:16Z","timestamp":1715400076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524424000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":104,"alternative-id":["S1931524424000355"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2024.02.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}